Literature DB >> 3924608

Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.

M Granström, B Wretlind, B Markman, O R Pavlovskis, M L Vasil.   

Abstract

Enzyme-linked immunosorbent assays were developed with four purified Pseudomonas aeruginosa extracellular proteins (exotoxin A, elastase, alkaline protease, and phospholipase C) to determine antibody levels in sera from healthy subjects and the serological response in patients colonized or infected with Pseudomonas aeruginosa. Five of 39 burn patients with wounds colonized by Pseudomonas aeruginosa had elevated antibody titers to alkaline protease. Response to the other antigens was found in only a few patients. Pseudomonas aeruginosa infections (septicemia, osteitis, pneumonia etc.) resulted in increased antibody levels to exotoxin A or phospholipase C in 15 of 22 patients. These findings suggest that repeated determinations of antibodies to Pseudomonas aeruginosa exotoxin A and phospholipase C might be used to monitor therapy in certain patients with osteitis and other deep Pseudomonas infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924608     DOI: 10.1007/BF02013597

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   5.103


  13 in total

1.  PSEUDOMONAS AERUGINOSA ELASTASE. ISOLATION, CRYSTALLIZATION, AND PRELIMINARY CHARACTERIZATION.

Authors:  K MORIHARA; H TSUZUKI; T OKA; H INOUE; M EBATA
Journal:  J Biol Chem       Date:  1965-08       Impact factor: 5.157

2.  Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.

Authors:  J D Klinger; D C Straus; C B Hilton; J A Bass
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

3.  Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections.

Authors:  M Granström; I G Julander; S A Hedström; R Möllby
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

Review 4.  Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends.

Authors:  A Cross; J R Allen; J Burke; G Ducel; A Harris; J John; D Johnson; M Lew; B MacMillan; P Meers
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

5.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

6.  Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  G Döring; H J Obernesser; K Botzenhart; B Flehmig; N Høiby; A Hofmann
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

7.  Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans.

Authors:  A S Cross; J C Sadoff; B H Iglewski; P A Sokol
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

8.  Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.

Authors:  K S Jagger; D L Robinson; M N Franz; R L Warren
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 11.677

9.  Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.

Authors:  M Granström; A Ericsson; B Strandvik; B Wretlind; O R Pavlovskis; R Berka; M L Vasil
Journal:  Acta Paediatr Scand       Date:  1984-11

10.  Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.

Authors:  K E Crowe; J A Bass; V M Young; D C Straus
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 11.677

View more
  6 in total

1.  Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

Authors:  R Ramphal; N Houdret; L Koo; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

2.  Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.

Authors:  M J Preston; J M Berk; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.

Authors:  J Grzybowski; E A Trafny; J Wrembel-Wargocka; J Patzer; D Dzierzanowska; I Zawistowska-Marciniak; M Kłos
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 11.677

4.  Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Authors:  A E Hollsing; M Granström; M L Vasil; B Wretlind; B Strandvik
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 11.677

5.  A Rapid and Sensitive Detection Method for Pseudomonas aeruginosa Using Visualized Recombinase Polymerase Amplification and Lateral Flow Strip Technology.

Authors:  Haitao Yang; Yan Wang; Qiankun Yang; Hui Fan; Lei Wang; Tianmeng Zhang; Zhixing Li; Gang Liu; Panpan Zhao; Huahua Wu; Jingquan Dong; Wei Liang
Journal:  Front Cell Infect Microbiol       Date:  2021-09-14       Impact factor: 5.293

6.  Generation of a recombinant antibody for sensitive detection of Pseudomonas aeruginosa.

Authors:  Gyu-Min Lim; Joo-Kyung Kim; Eun-Jung Kim; Chang-Soo Lee; Wooseong Kim; Byung-Gee Kim; Hee-Jin Jeong
Journal:  BMC Biotechnol       Date:  2022-08-04       Impact factor: 3.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.